FDA warning letters
A warning letter is FDA's formal notice that a company broke the law, usually found during an inspection. The company has 15 working days to reply. Letters that go unanswered lead to seizures, import bans or court orders.
1,872 letters match. Newest first.
-
DrugsTower Laboratories Ltd.
FDA warned Tower Laboratories, an OTC drug maker in Montague, MI, for weak out-of-specification investigations and unproven test methods.
High risk -
DrugsLiquidCapsule Manufacturing, LLC
LiquidCapsule Manufacturing failed CGMP (current good manufacturing practice) for OTC drugs, including component identity testing and process validation failures.
High risk -
DrugsAgebox Inc.
Agebox Inc. sells iKids-Growth children's supplements containing the undeclared, unapproved drug ibutamoren, making them unapproved and misbranded drugs.
High risk -
DrugsUnipack LLC
FDA says Unipack LLC released suppositories without adequate out-of-specification investigations, complete lab records, and required USP testing.
High risk -
DrugsPrivate Label Skin Care, Inc.
FDA warned Private Label Skin Care about poor quality oversight, continued sale of impurity-affected over-the-counter drugs, and missing drug listings.
High risk -
DevicesPalamur Biosciences Private Limited
FDA warns Palamur Biosciences over GLP violations in medical device safety testing and inadequate corrective actions.
High risk -
DrugsDevalingam Mahalingam, M.D., Ph.D.
FDA warns clinical investigator Devalingam Mahalingam, M.D., Ph.D. over a 100-fold investigational drug overdose that led to a subject's death.
High risk -
DrugsGuangdong Renhe Guozhuang Biotechnology Co., Ltd.
FDA warns Guangdong Renhe Guozhuang Biotechnology over CGMP failures in OTC drug manufacturing.
High risk -
DrugsAtomix LLC
FDA warned Atomix LLC that its website sells unapproved SARM drugs MK-2866 and RAD-140 as new drugs without approval.
High risk -
DrugsPrime Sports Nutrition
FDA warns Prime Sports Nutrition that its website sells SARMs such as LGD-4033 and RAD-140 as unapproved new drugs.
High risk -
DrugsPinnacle Professional Research dba Pinnacle Peptides
FDA told Pinnacle Peptides its SARMs sold online are unapproved new drugs with serious safety risks.
High risk -
DrugsDynamic Health Group dba SARMS AMERICA
FDA told SARMS AMERICA its SARMs products (Ostarine, MK-677, Cardarine, LGD-4033) are unapproved new drugs sold online without FDA approval.
High risk -
DrugsMaria A. Carballosa, M.D.
FDA warns Dr. Maria Carballosa over failure to retain clinical trial records for an investigational drug.
Medium -
DrugsMedinatura New Mexico, Inc.
FDA cited Medinatura New Mexico for drug manufacturing rule violations, including weak component testing and cleaning.
High risk -
DrugsSV Labs Corporation
SV Labs released microbe-contaminated OTC drug products and lacked water, process and quality controls, FDA says.
High risk -
DrugsDarmerica, LLC
FDA warns Darmerica over manufacturing-quality violations and mislabeled drug ingredients, including retatrutide.
High risk -
AnimalKing Farm
King Farm's horse feed held fumonisin up to 36.1 ppm; FDA ties it to at least 30 horse deaths.
High risk -
DrugsRevive Rx LLC dba Revive Rx Pharmacy
FDA warns Revive Rx Pharmacy over insanitary production of sterile compounded drugs, citing contamination risks.
High risk -
DevicesTG Supply LLC d/b/a TransGuy Supply
FDA warned TransGuy Supply that its breast binders are unregistered, unlisted medical devices.
Low -
DevicesFlux Lab Pte. Ltd. d/b/a The Fluxion
FDA warns Flux Lab/The Fluxion over unregistered, unlisted chest binders marketed as medical devices.
Medium -
DevicesMarli Washington Design, LLC
Marli Washington Design (gc2b) sold breast binders as medical devices without FDA registration or listing for FY2026, making them misbranded.
Low -
DevicesEarly to Bed, Inc.
FDA warned Early to Bed, Inc. that its breast binders are misbranded because the manufacturer was not registered or listed with FDA.
Low -
DevicesGenderBender LLC
GenderBender LLC sells breast binders as medical devices without FDA registration or listing, making them misbranded.
Low -
DevicesTomboyX, PBC
FDA says TomboyX sells breast binders as medical devices without registering or listing them, making them misbranded.
Medium -
DevicesPhiladelphia 7, Inc d/b/a Passional Boutique
FDA says Philadelphia 7 sold unregistered, unlisted breast binders, making them misbranded devices.
Low -
DevicesTOMSCOUT
FDA says TOMSCOUT sells breast binders as medical devices without required FDA registration or listing.
Low -
DevicesShapeShifter Apparel, LLC
FDA says ShapeShifter Apparel sold breast binders as unregistered, unlisted medical devices, making them misbranded.
Low -
DevicesTrans-Missie B.V.
FDA says Trans-Missie B.V. sells breast binders as medical devices without registering or listing them with FDA.
Low -
DrugsSklar Personal Care Inc.
Sklar Personal Care’s drug facility failed CGMP (current good manufacturing practice), including untested raw materials and inadequate cleaning, process validation, and quality oversight.
High risk -
Drugs3D Imaging Drug Design and Development LLC
FDA warns 3D Imaging of CGMP failures in sterile PET drug manufacturing and outdated drug listings.
High risk -
BiologicsGreen Valley Fertility Partners
FDA cited Green Valley Fertility Partners for donor eligibility failures involving oocyte HCT/Ps, including missing communicable disease testing and screening.
High risk -
BiologicsMicrovascular Tissue, Inc.
FDA says Microvascular Tissue's mVASC wound product is an unapproved drug and unlicensed biologic, made without validated processes.
High risk -
FoodHarbor Marine Product Inc.
FDA found Listeria bacteria on raw ready-to-eat fish contact surfaces and serious seafood HACCP and importer verification failures at Harbor Marine Product.
High risk -
FoodBedner Growers, Inc.
FDA: Bedner Growers' cucumbers tied to Salmonella outbreaks; packing line and product tested positive.
High risk -
OtherLongford Water Company LLC
FDA warns Longford Water Company that its bottled drinking water was made under insanitary conditions and without required treatment validation and testing.
High risk -
FoodTarget Corporation
FDA warns Target that recalled ByHeart infant formula tied to an infant botulism outbreak stayed on store shelves in 20 states.
High risk -
FoodWalmart, Inc.
Walmart kept recalled ByHeart infant formula on shelves in 21 states after a botulism outbreak recall, FDA says.
High risk -
FoodThe Kroger Company
FDA warned Kroger that recalled ByHeart infant formula tied to an infant botulism outbreak stayed on its store shelves.
High risk -
FoodThe Albertsons Companies Incorporated
FDA warns Albertsons that recalled ByHeart infant formula tied to 51 infant botulism cases stayed on its store shelves for days.
High risk -
DrugsCatalent Indiana, LLC
Catalent Indiana's Bloomington plant released sterile vials contaminated with mammalian hair and failed to investigate, FDA says.
High risk -
DrugsSeaway Pharma Inc.
FDA cited Seaway Pharma for manufacturing-quality rule violations in OTC oral liquid drugs, including release and component-testing failures.
High risk -
DrugsCDL Services, Inc. DBA Technichem
FDA warned CDL Services (Technichem), an Anaheim OTC drug maker, that it released hand sanitizer and hand soap batches without testing.
High risk -
DrugsDeVere Manufacturing Inc.
FDA warned DeVere Manufacturing in Janesville, Wisconsin, that its OTC hand sanitizers are adulterated after a June 2025 inspection found CGMP failures.
High risk -
DevicesEnvoy Medical Inc.
Envoy Medical in Saint Paul, MN was cited for quality system failures in making its Esteem II Implantable Hearing System, including slow complaint investigations and missed cleanroom contamination risks.
High risk -
FoodDelucas Bakery Corp
FDA warns Delucas Bakery Corp over unsanitary conditions, missing food safety plan, and undeclared allergens in ready-to-eat rolls and buns.
High risk -
DrugsRhyz Analytical Labs
FDA warned Rhyz Analytical Labs, a contract drug testing lab, that inadequate microbial failure investigations and quality oversight made tested drugs adulterated.
High risk -
DrugsPQ Pharmacy, LLC
FDA warns PQ Pharmacy, a Florida sterile drug compounder, that its products were made under unsafe conditions.
High risk -
DrugsTurbare Manufacturing
FDA warns outsourcing facility Turbare Manufacturing of Conway, Arkansas, for making sterile drugs under insanitary conditions.
High risk -
DrugsDistacart Inc.
FDA says Distacart's website sells unapproved drugs, some claimed for malaria, asthma, depression and eye conditions.
High risk -
DrugsSwift Digital Group LLC dba Swadesii
FDA warned Swadesii that its website sells unapproved drugs with claims to treat serious conditions including measles, cancer and Alzheimer's.
High risk